Conversion to tacrolimus alone compared to full immunosuppression following cardiac transplantation (TACTFUL).
Aaron P PearstonAmanda I IngemiZachary A ShaefferChad M CameronKatharine T BiagiMyra GobbleAmin YehyaDavid A BaranPublished in: Clinical transplantation (2023)
Selected patients who do not tolerate combination immunosuppression can be safely transitioned to tacrolimus monotherapy as a means of controlling adverse events without an increased risk of mortality or rejection.